Forest Laboratories, Inc. (NYSE: FRX) and Mylan Inc. (NYSE: MYL) announced that Mylan has received an approvable letter from the U.S. Food and Drug A
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Akela Pharma Inc said it received a letter from the U.S. Food and Drug Administration that its six-month inhalation toxicology studies for its lead p
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The popular anti-wrinkle drug Botox and a competitor have been linked to dangerous botulism symptoms in some users, cases so bad that a few children given the drugs for muscle spasms have died, the g
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The U.S. Food and Drug Administration notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactio
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
That's the interpretation from Tim Anderson, a securities analyst at Sanford Bernstein, who notes that the drugmaker hasn't crowed about receiving a 6-month priority review, even though last Friday
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The government on Friday proposed guidelines for how pharmaceutical companies can use medical journal articles to market drugs for unapproved uses. The Food and Drug Administration guidelines, critic
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Boehringer Ingelheim's investigational cancer treatment BIBW 2992 has recently received a Fast Track Designation status by the FDA. Under this designation, Boehringer Ingelheim will conduct a pivota
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
A renowned researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. Scott Pelley reports.
read more » Discuss Add this link to...Bury Add to:
| Bookmarks